Lenskart’s upcoming results are closely watched as investors assess growth momentum, margin improvement and the impact of its aggressive expansion. Analysts expect steady revenue gains, rising active shoppers and improving store economics. Despite valuation concerns, the long-term opportunity remains strong, supported by an under-penetrated market and Lenskart’s integrated, cost-efficient operating model.Read More

Nomura has initiated coverage on Anthem Biosciences with a Buy rating and a ₹740 target, citing attractive valuations, strong CRDMO positioning, diversified capabilities, and robust revenue and earnings growth projections despite recent stock correction.Read More

A 72-year-old Mumbai resident, Bharat Harakchand Shah, has filed a police complaint after discovering that his inherited equity portfolio—long believed to be growing—had allegedly been mismanaged, leading to a sudden demand for ₹35 crore. The case is now under investigation by Mumbai Police’s Economic Offences Wing, with an FIR filed against Globe Capital.Read More

Aequs Limited’s Rs 921.81-crore IPO opens on December 3 with strong grey-market interest, trading at a 21% premium over the upper price band of Rs 124. The issue includes a fresh offer and OFS, with listing expected on December 10. Pre-IPO participation by major funds signals solid institutional demand.Read More

Meesho’s upcoming IPO highlights the rise of India’s digital economy, driven by small towns. The company built its success by empowering micro-entrepreneurs and resellers, offering affordable products to a digitally connected ‘Bharat’. This strategy has fueled rapid growth, making it a significant player beyond metropolitan markets.Read More

Japan’s Nikkei 225 closed up 0.2% on Friday, extending its weekly gain despite a challenging November. Investor focus is shifting to upcoming central bank decisions, with Tokyo’s core inflation hinting at a potential Bank of Japan rate hike. U.S. tech stocks’ performance hinges on the Federal Reserve’s December interest rate outlook.Read More

Indian markets have hit fresh all-time highs, but most portfolios remain muted. Market expert Anshul Saigal says this is the ideal moment for long-term investors as valuations have corrected sharply after 14 months of consolidation. He highlights opportunities in capital goods, renewables, metals, banking, consumption and gold financiers, and explains why this phase is perfect...Read More

GMDC shares fell after a three-day surge as traders booked profits, following strong gains driven by a government incentive to boost rare earth magnet production. The stock faced short-term technical resistance, though long-term trends remain positive. Profit taking set in after optimism around GMDC’s role in India’s strategic minerals push.Read More

Sudeep Pharma’s strong stock market debut turned into an early rally, with shares gaining up to 8% after listing at a nearly 24% premium to the IPO price. The Rs 895 crore issue drew heavy demand across all investor categories, reflecting confidence in the company’s position in speciality pharma ingredients. While analysts see long-term potential...Read More

Sudeep Pharma’s strong stock market debut turned into an early rally, with shares gaining up to 8% after listing at a nearly 24% premium to the IPO price. The Rs 895 crore issue drew heavy demand across all investor categories, reflecting confidence in the company’s position in speciality pharma ingredients. While analysts see long-term potential...Read More